Ex Parte YAMANA et al - Page 10



          Appeal No. 2000-0482                                                        
          Application 08/569,256                                                      


          composition with compositions containing only components A and C,           
          there are no examples wherein the claimed composition is                    
          compared with a composition containing components A, C and a PTFE           
          having a molecular weight outside the claimed range.  Where, as             
          here, the appellant is relying on a claimed critical range to               
          define over the prior art, he must demonstrate that the results             
          of optimizing the molecular weight of the PTFE are unexpectedly             
          good.  See In re Antonie, 559 F.2d 618, 620, 195 USPQ 6, 8 (CCPA            
          1977)(“[I]t is not inventive to discover the optimum or workable            
          ranges by routine experimentation.”) See also, In re Best, 562              
          F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977)(“Where, as here,             
          the claimed and prior art products are identical or substantially           
          identical, or are produced by identical or substantially                    
          identical processes, the PTO can require an applicant to prove              
          that the prior art products do not necessarily or inherently                
          possess the characteristics of his claimed product.”)                       
                    Appellants also assert that Wagner teaches away from              
          combining low molecular weight PTFE with other release agents,              
          except mineral fillers, based on Wagner’s disclosure that while             
          “[t]he effectiveness of the polytetrafluoroethylene can                     
          frequently be increased by also using silicone oils . . . this              
                                          10                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007